Reports for EMTRICITABINE

Ingredient

EMTRICITABINE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2021-04-09 2021-06-07 137241
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 200MG 300MG TABLET Avoided shortage 2020-04-29 2020-07-09 113424
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 600MG 200MG 300MG TABLET Avoided shortage 2020-12-07 2021-02-03 129766
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 600MG 200MG 300MG TABLET Resolved 2021-04-12 2021-06-03 137370
TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR 600MG 200MG 300MG TABLET Resolved 2020-04-16 2020-05-08 112370
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 300MG 200MG TABLET Resolved 2018-04-27 2019-06-19 47356
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 300MG 200MG TABLET Resolved 2019-06-25 2019-07-03 87463
PMS-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 600MG 300MG 200MG TABLET Resolved 2022-08-15 2022-10-24 166805

Showing 21 to 28 of 28

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ATRIPLA 300MG 200MG 600MG TABLET Discontinued 2021-08-17 2022-01-01 144260

Showing 1 to 1 of 1